Lymphocytes: potential mediators of postischemic injury and neuroprotection
- PMID: 17261738
- DOI: 10.1161/01.STR.0000248425.59176.7b
Lymphocytes: potential mediators of postischemic injury and neuroprotection
Abstract
Antigen-nonspecific inflammation appears to contribute to postischemic brain injury. Because there is a breach in the integrity of the blood-brain barrier after stroke, the immune system encounters novel central nervous system (CNS) antigens that allow for the development of a CNS antigen-specific autoimmune response. The nature of the immune response generated on antigen encounter is determined by the microenvironment at the site of antigen encounter. For instance, a systemic inflammatory response, such as that which would accompany an infection, could alter the microenvironment in such a way as to promote the initiation of deleterious autoimmunity. If patients who develop an infection in the immediate poststroke period are predisposed toward a CNS autoimmune response, it might help to explain why infection after stroke is associated with increased disability. We present data to support this hypothesis and to show that the breach in the blood-brain barrier can also be capitalized on to modulate the immune response to create a neuroprotective environment after stroke.
Similar articles
-
Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke.J Neuroinflammation. 2014 Dec 24;11:213. doi: 10.1186/s12974-014-0213-4. J Neuroinflammation. 2014. PMID: 25539803 Free PMC article. Review.
-
Autoimmune responses to the brain after stroke are associated with worse outcome.Stroke. 2011 Oct;42(10):2763-9. doi: 10.1161/STROKEAHA.111.619593. Epub 2011 Jul 28. Stroke. 2011. PMID: 21799171 Free PMC article.
-
Resveratrol neuroprotection in stroke and traumatic CNS injury.Neurochem Int. 2015 Oct;89:75-82. doi: 10.1016/j.neuint.2015.08.009. Epub 2015 Aug 12. Neurochem Int. 2015. PMID: 26277384 Free PMC article. Review.
-
How do immune cells overcome the blood-brain barrier in multiple sclerosis?FEBS Lett. 2011 Dec 1;585(23):3770-80. doi: 10.1016/j.febslet.2011.04.066. Epub 2011 May 4. FEBS Lett. 2011. PMID: 21550344 Review.
-
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury.Pharmacol Res. 2014 Aug;86:26-31. doi: 10.1016/j.phrs.2014.05.009. Epub 2014 May 27. Pharmacol Res. 2014. PMID: 24874648 Review.
Cited by
-
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.Neurotherapeutics. 2016 Oct;13(4):729-747. doi: 10.1007/s13311-016-0460-4. Neurotherapeutics. 2016. PMID: 27492770 Free PMC article. Review.
-
Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain.Br J Pharmacol. 2010 Feb;159(4):808-11. doi: 10.1111/j.1476-5381.2009.00527.x. Epub 2009 Dec 10. Br J Pharmacol. 2010. PMID: 20015295 Free PMC article.
-
Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation.J Transl Med. 2022 Aug 16;20(1):369. doi: 10.1186/s12967-022-03570-w. J Transl Med. 2022. PMID: 35974336 Free PMC article. Review.
-
Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice.PLoS One. 2011;6(10):e25863. doi: 10.1371/journal.pone.0025863. Epub 2011 Oct 21. PLoS One. 2011. PMID: 22031820 Free PMC article.
-
Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier.Stroke. 2015 Jun;46(6):1681-9. doi: 10.1161/STROKEAHA.115.009099. Epub 2015 Apr 28. Stroke. 2015. PMID: 25922503 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources